Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Jan Debruyne
Observed names:
Debruyne, Jan,
J C Debruyne,
J. C. Debruyne,
Jan C Debruyne
Observed institutions:
Vrije Universiteit Brussel,
Ghent University Hospital,
Ghent University,
NeuroRx Research (Canada),
University of Bari Aldo Moro,
Vrije Universiteit Amsterdam,
Amsterdam UMC Location Vrije Universiteit Amsterdam
show all 7
OpenAlex ID:
A5103518987
Siponimod versus placebo in secondary progressive multiple sclerosis (EXPAND): a double-blind, randomised, phase 3 study
2018
·
Ludwig Kappos
, Amit Bar-Or
, et al.
·
The Lancet
·
940
PET visualization of microglia in multiple sclerosis patients using [ 11 C]PK11195
2003
·
J. C. Debruyne
, J. Versijpt
, et al.
·
European Journal of Neurology
·
217
Diagnostic criteria for chronic lymphocytic inflammation with pontine perivascular enhancement responsive to steroids (CLIPPERS)
2017
·
W Oliver Tobin
, Yong Guo
, et al.
·
Brain
·
205
Microglial imaging with positron emission tomography and atrophy measurements with magnetic resonance imaging in multiple sclerosis: a correlative study
2005
·
J Versijpt
, J C Debruyne
, et al.
·
Multiple Sclerosis Journal
·
127
White-Matter Astrocytes, Axonal Energy Metabolism, and Axonal Degeneration in Multiple Sclerosis
2012
·
Melissa Cambron
, Miguel D'Haeseleer
, et al.
·
Journal of Cerebral Blood Flow & Metabolism
·
114
PDF
Consensus guidelines on the neurologist's role in the management of neurogenic lower urinary tract dysfunction in multiple sclerosis
2013
·
Dirk De Ridder
, Frank Van Der Aa
, et al.
·
Clinical Neurology and Neurosurgery
·
57
Improvement of Hepatic Myelopathy after Liver Transplantation
1999
·
Roberto Troisi
, Jan Debruyne
, et al.
·
New England Journal of Medicine
·
44
PDF
Semiquantification of the peripheral-type benzodiazepine ligand [11C]PK11195 in normal human brain and application in multiple sclerosis patients.
2002
·
Jan C Debruyne
, Koen J Van Laere
, et al.
·
PubMed
·
41
Fluoxetine in progressive multiple sclerosis: The FLUOX-PMS trial
2019
·
Melissa Cambron
, Jop Mostert
, et al.
·
Multiple Sclerosis Journal
·
38
PDF
In vitro TNF-α, IL-2 and IFN-γ production as markers of relapses in multiple sclerosis
1996
·
Jan Philippé
, Jan Debruyne
, et al.
·
Clinical Neurology and Neurosurgery
·
33
Do Flexible Goal Adjustment and Acceptance Help Preserve Quality of Life in Patients with Multiple Sclerosis?
2015
·
Stefaan Van Damme
, Annelies De Waegeneer
, et al.
·
International Journal of Behavioral Medicine
·
30
PDF
Diffusion weighted callosal integrity reflects interhemispheric communication efficiency in multiple sclerosis
2008
·
Nele P. Warlop
, Eric Achten
, et al.
·
Neuropsychologia
·
27
Safety and efficacy of natalizumab in Belgian multiple sclerosis patients: subgroup analysis of the natalizumab observational program
2014
·
Vincent van Pesch
, Emmanuel Bartholomé
, et al.
·
Acta Neurologica Belgica
·
23
Transverse diffusivity of cerebral parenchyma predicts visual tracking performance in relapsing–remitting multiple sclerosis
2009
·
Nele P. Warlop
, Eric Achten
, et al.
·
Brain and Cognition
·
23
Fluoxetine in Progressive Multiple Sclerosis (FLUOX-PMS): study protocol for a randomized controlled trial
2014
·
Melissa Cambron
, Jop Mostert
, et al.
·
Trials
·
22
PDF
Natalizumab treatment shows low cumulative probabilities of confirmed disability worsening to EDSS milestones in the long-term setting
2018
·
Maria Trojano
, Helmut Butzkueven
, et al.
·
Multiple Sclerosis and Related Disorders
·
19
PDF
The relation between goal adjustment, goal disturbance, and mental well-being among persons with multiple sclerosis
2019
·
Stefaan Van Damme
, Sara Kindt
, et al.
·
Psychology and Health
·
17
PDF
Relapse markers in multiple sclerosis: are in vitro cytokine production changes reflected by circulatory T-cell phenotype alterations?
1998
·
Jan Debruyne
, Jan Philippé
, et al.
·
Multiple Sclerosis Journal
·
16
Callosal function in MS patients with mild and severe callosal damage as reflected by diffusion tensor imaging
2008
·
Nele P. Warlop
, Els Fieremans
, et al.
·
Brain Research
·
13
Serum Alpha-Linolenic Acid and Long-Term Multiple Sclerosis Activity and Progression
2025
·
Marianna Cortese
, Xiaojing Peng
, et al.
·
Neurology
·
4
PDF
Targeting phosphocreatine metabolism in relapsing–remitting multiple sclerosis: evaluation with brain MRI, 1H and 31P MRS, and clinical and cognitive testing
2018
·
Melissa Cambron
, Tatjana Reynders
, et al.
·
Journal of Neurology
·
3
Clinical, Radiographic and Pathological Features of CLIPPERS (Chronic Lymphocytic Inflammation with Pontine Perivascular Enhancement Responsive to Steroids) (P6.109)
2016
·
W. Oliver Tobin
, Yong Guo
, et al.
·
Neurology
Mitoxantronchemotherapie voor de behandeling van multiple sclerose
2009
·
Lore Lapeire
, Jan Debruyne
, et al.
·
Ghent University Academic Bibliography (Ghent University)
Inflammatoire parameters van ziekteactiviteit bij multiple sclerose : immunologische positron emissie : tomografische studie
2004
·
Jan Debruyne
·
Ghent University Academic Bibliography (Ghent University)
Multiple Sclerose.
1994
·
Debruyne, Jan
·
Ghent University Academic Bibliography (Ghent University)
Show more works
View as search
Works count:
28
Citation count:
2,011
H-index:
17
I10-index:
19
Year
Topic
Type